Leucine Rich Bio Private Limited is a Bioinformatics driven company based in the Silicon Valley of India, Bangalore, specializing in Next Generation Sequencing (NGS) Data Analysis & Interpretation. Our area of focus is in Human Genome Interpretation, especially for clinical and research use. We use advances in the area of Computer Science, Information Science, Data Management, Statistics and Systems Biology to solve complex problems in Genomics. We envision using cutting edge big data approaches along with machine learning algorithms to delve deeper into the understanding of the human genome and develop novel solutions to drug discovery.
Advanced Genome Interpretation Suite (AGIS) is a Clinical Data Analysis Platform for Analyzing and Interpreting Clinically Relevant Sequence information from Human Genomes. AGIS uses powerful algorithms to report precise Disease Causing Mutations. AGIS’s algorithms are designed to provide information in a fast yet accurate manner. AGIS inputs Sequence Reads and outputs mutation analysis reports. AGIS reports are also tailored for clinicians where actionable mutations are reported. AGIS has undergone extensive testing for accuracy, sensitivity and specificity. AGIS runs on the cloud and can be accessed from any location.
In this era of personalized/precision medicine, fast and accurate diagnosis is key for proper prognosis and treatment of diseases. We at Leucine Rich Bio understand the relevance and scope of NGS data that can deliver meaningful and actionable information to diagnostic companies and clinicians.
We at Leucine Rich Bio understand the complexity of the NGS data analysis and would offer our proprietary data analysis platforms to researchers so as to enable discovering and deciphering of the genomic data in a simple, efficient and effective manner.